Apimeds Pharmaceuticals US, Inc. reports

Company location: Matawan, NJ
Fiscal year end: 31 December

Apimeds Pharmaceuticals US, Inc. has filed 118 SEC EDGAR filings since 29 Jan 2024

Filter by type:
10-K
10-Q
8-K

SEC filing history

Showing 1-20 of 20 matching filings.

Per page

Current page

8-K File 001-42545

CURRENT REPORT

Filing date: 05 May 2026
Reporting date: 05 May 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 04 May 2026
Reporting date: 24 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

FORM 8-K

Filing date: 22 Apr 2026
Reporting date: 17 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Apr 2026
Reporting date: 15 Apr 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date: 09 Apr 2026
Reporting date: 20 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 26 Mar 2026
Reporting date: 20 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 25 Mar 2026
Reporting date: 20 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Mar 2026
Reporting date: 16 Mar 2026
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K/A File 001-42545

AMENDMENT NO. 2 TO FORM 8-K

Filing date: 17 Feb 2026
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 02 Jan 2026
Reporting date: 30 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 10 Dec 2025
Reporting date: 05 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date: 10 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 02 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 18 Nov 2025
Reporting date: 13 Nov 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Oct 2025
Reporting date: 15 Oct 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 16 Jul 2025
Reporting date: 15 Jul 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 05 Jun 2025
Reporting date: 30 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 20 May 2025
Reporting date: 16 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 12 May 2025
Reporting date: 08 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-42545

CURRENT REPORT

Filing date: 15 Apr 2025
Reporting date: 11 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing